Part
1
Part
2
2.1
含量和含量均匀度
2.2
有关物质
2.3
溶出度与溶出曲线
Part
3
参考文献
[1] 国家药品监督管理局. 药品上市后变更管理办法(试行)[EB/OL]. [2021-1-12].https://www.nmpa.gov.cn/xxgk/ggtg/qtggtg/20210113142301136. html.
[2] YIN J, JIN F F, NAN N, et al. Study on the critical quality attributes of lorazepam tablets[J]. Drug Eval Res(药物评价研究), 2018, 41(9): 1630-1639.
[3] ZHAI T W. Discussion on critical process parameters in drug production[J]. Chem Pharm Eng(化工与医药工程), 2019,40(3): 35-38.
[4] GUO Q H, ZHANG Z C, HAN H L, et al. Discussion on the average of content uniformity of nifedipine tablets as the content result[J]. Drug Stand China(中国药品标准), 2021,22(3): 279-282.
[5] 国家食品药品监督管理局高级研修学院. 药品检验技术[M].北京: 中国医药科技出版社, 2013: 182.
[6] 高爱国. 浅谈片剂制粒工艺控制[J]. 齐鲁药事, 2009, 28(3):187-188.
[7] CAVINATO M, BRESCIANI M, MACHIN M, et al. The development of a novel formulation map for the optimization of high shear wet granulation[J]. Chem Eng J, 2010, 164(2/3):350-358.
[8] CHEN X, WANG Q Q, WU X, et al. Study on the correlation of water content and related substances in phenoxymethylpenicillin potassium tablets[J]. Chin Pharm Aff(中国药事), 2013, 27(11):1203-1206.
[9] 姜雄平. 仿制药一致性评价[C]//全国医药技术市场协会. 仿制药参比制剂对照、质量评价方法及申报资料技术要求研讨会论文集. 2013: 3-22.
[10] XIONG X, PEI K, GUO Y F, et al. Study on the dissolution behavior and influencing factors of Erdosteine capsules and tablets[J]. China Pharm(中国药师), 2019, 22(5): 923-928.
[11] 李锦璐, 黄健. 不同粒径的原料对阿莫西林胶囊溶出曲线的影响[J]. 北方药学, 2019, 16(2): 11-12.
[12] WANG R Y, LIU Y, DURIG T. Comparison of binder in roller compaction[J]. Chin J Mod Appl Pharm(中国现代应用药学), 2016, 33(12): 1543-1547.
[13] ZHANG R, WANG H, CHEN Y S, et al. Preparation and quality evaluation of tamoxifen citrate tablets[J]. Chin J Mod Appl Pharm(中国现代应用药学), 2019, 36(20): 2535-2538.
[14] LIU C, ZONG J F, MENG Q T. Formulation and process design and quality control analysis of chemical generic preparations[J]. Chin J Pharm(中国医药工业杂志), 2021,52(3): 299-311.
[15] CHEN H. Study on high shear wet granulation process for Losartan Potassium tablets[J]. J Shenyang Pharm Univ(沈阳药科大学学报), 2017, 34(6): 461-466, 502.
[16] YE X J, CHEN Y. Dissolution testing of glimepiride tablets and evaluation of in vivo-in vitro correlation[J]. Pharm Today(今日药学), 2021, 31(1): 35-38.
[17] HU L B, ZHU H J, CHEN H, et al. Evaluation of critical process parameters for intra-tablet coating uniformity of pioglitazone hydrochloride[J]. Chin J Mod Appl Pharm(中国现代应用药学), 2016, 33(4): 436-440.
撰稿人 | 许静玉、唐谦、钱璟、石蔚华、胡涛、高建青
责任编辑 | 胡静
审核人 | 何发
2024-09-02
2024-09-04
2024-09-23
2024-08-28
2024-09-27
2024-08-27
2024-09-09
近年来,RNA疗法及其在疾病治疗中的潜力备受关注,今年诺贝尔生理学或医学奖授予微小RNA(microRNA)领域的研究更是将这一热度推向高峰。在新药研发蓬勃发展的今天,小核酸药物被视为继小分子药和抗体药之后的“第三次制药浪潮”的关键力量。
作者:崔芳菲
评论
加载更多